Trump Announces Deal to Drop Obesity Drug Prices to as Little as $149 a Month
President Trump announced a deal with pharmaceutical companies Eli Lilly and Novo Nordisk to lower the prices of obesity drugs for Medicare, Medicaid, and self-paying patients. The deal aims to make these weight-loss medications more accessible and affordable for Americans. Under the agreement, the prices of the drugs will be reduced to as little as $149 per month, making them more financially viable for a broader segment of the population. This move is seen as a step towards addressing the growing obesity epidemic in the United States and improving overall public health. The announcement highlights the administration's efforts to tackle rising healthcare costs and ensure that essential medical treatments are within reach of those who need them.
Source: For the complete article, please visit the original source link below.
